CN216824337U - Novel implanted drug delivery device - Google Patents

Novel implanted drug delivery device Download PDF

Info

Publication number
CN216824337U
CN216824337U CN202122738899.5U CN202122738899U CN216824337U CN 216824337 U CN216824337 U CN 216824337U CN 202122738899 U CN202122738899 U CN 202122738899U CN 216824337 U CN216824337 U CN 216824337U
Authority
CN
China
Prior art keywords
cavity
cover
upper cover
pipe
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202122738899.5U
Other languages
Chinese (zh)
Inventor
戴华英
李健
张昆
回广雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Demak Medical Instrument Co ltd
Original Assignee
Tianjin Dimak Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Dimak Pharmaceutical Technology Co ltd filed Critical Tianjin Dimak Pharmaceutical Technology Co ltd
Priority to CN202122738899.5U priority Critical patent/CN216824337U/en
Application granted granted Critical
Publication of CN216824337U publication Critical patent/CN216824337U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The utility model relates to the technical field of implantable therapeutic infusion instruments, in particular to a novel implantable drug delivery device which has stable use effect and overall structure and better use reliability, and comprises a guide tube, a port body base and a port body upper cover, wherein the port body base and the port body upper cover are in sliding fit, the port body upper cover is provided with an operation opening, a through cavity is formed in the operation opening, an upper cavity cover is arranged in the through cavity, a lower cavity seat is arranged in the upper cavity cover, an injection piece is arranged between the lower cavity seat and the upper cavity cover, the upper end and the lower end of the injection piece are respectively butted against the upper cavity cover and the lower cavity cover, the port body base is connected with a limiting ring, the lower cavity seat is arranged in the limiting ring, a sleeve is communicated on the lower cavity seat and is matched with a connecting tube, the connecting tube is connected with a gradual change tube, a gradual change groove is formed in the port body upper cover, the gradual change tube is arranged in the gradual change groove, the port body base is connected with a gradual change pressure tube, the guide tube cover is established on the connecting pipe, is provided with the pipe lock on the guide tube, is provided with the lag on the pipe lock.

Description

Novel implanted drug delivery device
Technical Field
The utility model relates to the technical field of implantable therapeutic infusion apparatuses, in particular to a novel implantable drug delivery device.
Background
As is well known, with the continuous improvement of the medical level of human being, more and more difficult diseases are diagnosed and treated, when patients need to be treated by infusion for a long time due to the particularity of the diseases, an implantable drug delivery device structure is usually used for relieving the pain of the patients, and the implantable drug delivery device is a venous infusion device which can be implanted into the bodies of the patients, and can be used for assisting in the aspects of frequent infusion of various drugs, fluid infusion, nutrition support treatment, blood transfusion, blood sample collection and the like so as to reduce the pain and difficulty of repeated puncture.
The existing implanted type drug delivery device structure generally comprises a port body and a guide tube, wherein the port body is communicated with the guide tube, an injection piece is arranged in the port body, the port body and the guide tube are made of flexible materials, when the device is used, the guide tube is arranged in a vein of a human body through subcutaneous puncture by utilizing an operation method, the rest guide tubes and the port body are buried in subcutaneous tissues, a circular bulge can be touched only on the body surface of a patient, the circular bulge is positioned from the position during treatment, a nondestructive needle is vertically punctured into the port body through the skin, the device can be used for infusing various medicines, supplementing liquid, nutrition support treatment, blood transfusion, blood sample collection and the like, a reliable vein channel is provided for the patient needing long-term infusion treatment, and the device can also be used for blood sample collection.
However, the harbor body in the above-mentioned implanted drug delivery device structure is made of flexible material, so after being implanted into subcutaneous tissue, the muscle activity at the implanted part is dragged by the movement of the patient, which easily causes the extrusion deformation of the internal cavity of the harbor body, and affects the use effect.
SUMMERY OF THE UTILITY MODEL
Technical problem to be solved
Aiming at the defects of the prior art, the utility model provides a novel implantable drug delivery device, wherein the cavity volume formed by matching an upper cavity cover and a lower cavity base is stable and not easy to deform, the using effect is stable, the structure is stable, and the using reliability is good.
(II) technical scheme
In order to achieve the purpose, the utility model provides the following technical scheme: a novel implantable drug delivery device comprises a guide tube, a harbor body base and a harbor body upper cover, wherein the harbor body base is in sliding fit with the harbor body upper cover, an operation opening is formed in the harbor body upper cover, a through cavity is formed in the operation opening, an upper cavity cover is arranged in the through cavity, a lower cavity seat is arranged in the upper cavity cover, an injection piece is arranged between the lower cavity seat and the upper cavity cover, the injection piece is made of soft materials and penetrates through the operation opening, the top of the injection piece is streamline, the upper end and the lower end of the injection piece are respectively abutted against the upper cavity cover and the lower cavity seat, a limiting ring is fixedly connected onto the harbor body base, the lower cavity seat is arranged in the limiting ring, a sleeve is communicated onto the lower cavity seat, a connecting pipe is in interference fit in the sleeve, a gradual-changing pipe is fixedly connected onto the connecting pipe, a gradual-changing groove is formed in the harbor body upper cover, and the gradual-changing pipe is arranged in the gradual-changing groove, the harbor body base is fixedly connected with a gradual change compression pipe used for compressing the gradual change pipe, the guide pipe is sleeved on the connecting pipe, a guide pipe lock is arranged on the guide pipe, and a protective sleeve is arranged on the guide pipe lock.
On the basis of the above scheme, a plurality of annular grooves are formed in the catheter lock, a plurality of protruding rings are arranged in the protective sleeve, and the plurality of protruding rings are respectively arranged in the plurality of annular grooves.
On the basis of the above scheme, the upper part of the outer periphery of the upper cover of the harbor body is a sewing part, the sewing part is of a curved surface structure, and the lower part of the outer periphery of the upper cover of the harbor body is a holding part and a cylindrical surface structure of the holding part.
In a further aspect of the present invention, the suture portion is provided with a plurality of suture holes for subcutaneous suture.
As a further aspect of the above solution, the upper chamber cover and the lower chamber base may be formed by machining, punch forming or metallurgical injection molding, and both the upper chamber cover and the lower chamber base are made of stainless steel or titanium alloy.
As a further improvement of the above scheme, the harbor body base and the harbor body upper cover are both made of plastic materials and are integrally injection molded.
As a further scheme of the scheme, ultrasonic welding is adopted between the harbor body base and the harbor body upper cover.
(III) advantageous effects
Compared with the prior art, the utility model provides a novel implantable drug delivery device, which has the following beneficial effects:
1. This novel implanted device of dosing through the cooperation of upper chamber lid and lower chamber seat, is convenient for form the support to the cavity that the cooperation formed between port body base and the port body upper cover, cavity non-deformable, the result of use is comparatively stable.
2. This novel implanted device of dosing through the gradual change pipe and the gradual change cooperation that compresses tightly the pipe, is convenient for be connected between connecting pipe and the sleeve pipe, through the cooperation of pipe lock with the connecting pipe, can compress tightly the guiding tube for the connecting pipe, makes being connected between guiding tube and the connecting pipe comparatively reliable and stable, and this novel implanted device of dosing's functional structure is comparatively stable.
Drawings
FIG. 1 is an exploded top perspective view of the present invention;
FIG. 2 is an enlarged view of a portion of FIG. 1A;
FIG. 3 is a schematic bottom perspective view of the present invention;
FIG. 4 is an enlarged view of a portion of FIG. 3 at B according to the present invention;
FIG. 5 is a schematic perspective view of the present invention;
fig. 6 is a schematic cross-sectional perspective view of the protective cover and the projecting ring of the present invention.
In the figure: 1. a guide tube; 2. a harbor body base; 3. covering the harbor body; 5. an upper chamber cover; 6. a lower cavity seat; 7. an injection member; 8. a limiting ring; 9. a sleeve; 10. a connecting pipe; 11. a transition tube; 12. gradually transforming and tightening the tube; 13. a catheter lock; 14. a protective sleeve; 16. an annular groove; 17. a projecting ring; 18. a suture site; 19. pinching the part; 20. and (6) sewing the holes.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Examples
Referring to fig. 1-6, a novel implantable drug delivery device comprises a guiding tube 1, a harbor body base 2 and a harbor body upper cover 3, wherein the upper portion of the outer periphery of the harbor body upper cover 3 is a suturing portion 18, the suturing portion 18 is a curved surface structure, the suturing portion 18 is provided with a plurality of suturing holes 20 for suturing under the skin, which facilitates suturing in the body of a patient, the lower portion of the outer periphery of the harbor body upper cover 3 is a holding portion 19, the holding portion 19 has a cylindrical surface structure, which facilitates the holding of the harbor body upper cover 3, and has good practicability, the harbor body base 2 and the harbor body upper cover 3 are in sliding fit, the harbor body base 2 and the harbor body upper cover 3 are both integrally injection-molded by plastic materials, the harbor body base 2 and the harbor body upper cover 3 are welded by ultrasonic, which improves the connection reliability between the harbor body upper cover 3 and the harbor body base 2, the harbor body upper cover 3 is provided with an operation opening, the operation opening is provided with a through cavity, the inner cavity penetrating cavity is provided with an upper cavity cover 5, the upper cavity cover 5 is internally provided with a lower cavity seat 6, through the matching of the upper cavity cover 5 and the lower cavity seat 6, the support of a cavity formed by matching between the harbor body base 2 and the harbor body upper cover 3 is convenient to form, the cavity is not easy to deform, the using effect is stable, the upper cavity cover 5 and the lower cavity seat 6 can be machined, punched or metallurgically injection-molded, the upper cavity cover 5 and the lower cavity seat 6 are both made of stainless steel or titanium alloy, the structural strength of the upper cavity cover 5 and the lower cavity seat 6 is improved, the service life is prolonged, and the rejection with a human body is low.
It should be further noted that an injection member 7 is arranged between the lower cavity base 6 and the upper cavity cover 5, the injection member 7 is made of soft material, the injection member 7 passes through the operation opening, the top of the injection member 7 is streamlined, the upper end and the lower end of the injection member 7 are respectively abutted against the upper cavity cover 5 and the lower cavity base 6, a limit ring 8 is fixedly connected to the port body base 2, the lower cavity base 6 is arranged in the limit ring 8, a sleeve 9 is communicated with the lower cavity base 6, a connecting pipe 10 is in interference fit in the sleeve 9, a transition pipe 11 is fixedly connected to the connecting pipe 10, a transition groove is formed in the port body upper cover 3, the transition pipe 11 is arranged in the transition groove, a compression transition pipe 12 for compressing the transition pipe 11 is fixedly connected to the port body base 2, the connection between the connecting pipe 10 and the sleeve 9 is facilitated through the cooperation of the transition pipe 11 and the transition compression pipe 12, the guide pipe 1 is sleeved on the connecting pipe 10, be provided with pipe lock 13 on the guide tube 1, through the cooperation of pipe lock 13 and connecting pipe 10, can compress tightly guide tube 1 for connecting pipe 10, make being connected between guide tube 1 and the connecting pipe 10 comparatively reliable and stable, this novel implanted device of dosing's functional structure is comparatively stable, be provided with lag 14 on the pipe lock 13, a plurality of ring channels 16 have been seted up on the pipe lock 13, be provided with a plurality of bulge loops 17 in the lag 14, a plurality of bulge loops 17 set up respectively in a plurality of ring channels 16, improve the connection reliability of protection on pipe lock 13, positional stability is better.
To sum up, the working principle and the working process of the novel implantable drug delivery device are that when the novel implantable drug delivery device is used, firstly, the novel implantable drug delivery device is implanted into a patient body in an operation mode, the guide tube 1 is implanted into a venous blood vessel, after the implantation is completed, the non-damage needle is inserted into a cavity formed by matching the upper cover 5 and the lower cavity base 6 through the special non-damage needle, and various drugs, infusion solutions or nutrient solutions are infused into the cavity through the special non-damage needle, so that the infusion of various drugs, infusion solutions or nutrient solutions into the patient body is realized.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the utility model, the scope of which is defined in the appended claims and their equivalents.

Claims (7)

1. A novel implantable drug delivery device comprises a guide tube (1), and is characterized in that: still include harbour body base (2) and harbour body upper cover (3), be sliding fit between harbour body base (2) and the harbour body upper cover (3), the operation mouth has been seted up on harbour body upper cover (3), the interior chamber that runs through that has seted up of operation mouth, it is provided with upper chamber lid (5) to run through the intracavity, be provided with cavity seat (6) down in upper chamber lid (5), be provided with injection (7) between cavity seat (6) and upper chamber lid (5) down, injection (7) are soft material, and injection (7) pass the operation mouth, and the top of injection (7) is streamlined, and the upper and lower both ends of injection (7) respectively with upper chamber lid (5) and cavity seat (6) mutual butt, fixedly connected with spacing ring (8) on harbour body base (2), cavity seat (6) are down set up in spacing ring (8), the intercommunication has sleeve pipe (9) on cavity seat (6), the joint is characterized in that a connecting pipe (10) is arranged in the sleeve (9) in an interference fit mode, a gradual change pipe (11) is fixedly connected onto the connecting pipe (10), a gradual change groove is formed in the harbor body upper cover (3), the gradual change pipe (11) is arranged in the gradual change groove, a gradual change compression pipe (12) which is used for the gradual change pipe (11) to compress tightly is fixedly connected onto the harbor body base (2), the connecting pipe (10) is sleeved with a guide pipe (1), a guide pipe lock (13) is arranged on the guide pipe (1), and a protective sleeve (14) is arranged on the guide pipe lock (13).
2. The novel implantable drug delivery device of claim 1, wherein: the catheter lock (13) is provided with a plurality of annular grooves (16), a plurality of protruding rings (17) are arranged in the protecting sleeve (14), and the protruding rings (17) are respectively arranged in the annular grooves (16).
3. The novel implantable drug delivery device of claim 2, wherein: the harbour body upper cover is characterized in that the upper part of the periphery of the harbour body upper cover (3) is a sewing part (18), the sewing part (18) is of a curved surface structure, the lower part of the periphery of the harbour body upper cover (3) is a holding part (19), and the holding part (19) is of a cylindrical surface structure.
4. A novel implantable drug delivery device as claimed in claim 3, wherein: the suture part (18) is provided with a plurality of suture holes (20) for subcutaneous suture.
5. The novel implantable drug delivery device of claim 4, wherein: the upper cavity cover (5) and the lower cavity base (6) can be formed by machining, punch forming or metallurgical injection molding, and the upper cavity cover (5) and the lower cavity base (6) are both made of stainless steel or titanium alloy.
6. The novel implantable drug delivery device of claim 5, wherein: the harbor body base (2) and the harbor body upper cover (3) are made of plastic materials and are integrally injection molded.
7. The novel implantable drug delivery device of claim 6, wherein: the harbor body base (2) and the harbor body upper cover (3) are welded by ultrasonic.
CN202122738899.5U 2021-11-10 2021-11-10 Novel implanted drug delivery device Active CN216824337U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202122738899.5U CN216824337U (en) 2021-11-10 2021-11-10 Novel implanted drug delivery device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202122738899.5U CN216824337U (en) 2021-11-10 2021-11-10 Novel implanted drug delivery device

Publications (1)

Publication Number Publication Date
CN216824337U true CN216824337U (en) 2022-06-28

Family

ID=82101796

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202122738899.5U Active CN216824337U (en) 2021-11-10 2021-11-10 Novel implanted drug delivery device

Country Status (1)

Country Link
CN (1) CN216824337U (en)

Similar Documents

Publication Publication Date Title
US4723948A (en) Catheter attachment system
CN103002942A (en) Artificial blood vessel and access port of artificial blood vessel
CN217938823U (en) Infusion port device of dosing
CN216824337U (en) Novel implanted drug delivery device
US8460253B2 (en) Magnetically sealed intravenous access valve
CN113975521A (en) Novel implanted drug delivery device
CN113855920A (en) Vertical indwelling needle assembly and base structure thereof
CN113633875A (en) Double-cavity radiography catheter
CN216366181U (en) Vertical indwelling needle assembly and base structure thereof
CN204468880U (en) One is applicable to infant negative-pressure type quiet/needle of retaining on artery
CN217286741U (en) Medical implantable drug delivery device
CN219645838U (en) Magnetic positioning abdominal cavity chemotherapy device
CN211068447U (en) Novel anti-thrombus venous indwelling needle
CN213031508U (en) Implantable drug delivery device
CN212262047U (en) Implantable drug delivery device
CN215460909U (en) Implantable drug delivery device
CN114377246A (en) Port administration device and method for treating chronic pain
CN220275605U (en) Blood sampling indwelling needle
CN214550516U (en) Implanted abdominal cavity subcutaneous chemotherapy device
CN219323732U (en) Puncture-preventing transfusion harbor positioner
CN216258707U (en) Implantable drug delivery device
CN215690920U (en) Double-cavity radiography catheter
CN215460910U (en) Transfusion port device
CN220898763U (en) Detachable arteriovenous internal fistula puncture blood taking needle
CN218684618U (en) Injectable PICC (peripherally inserted central catheter) tube-placing subcutaneous tunnel building assembly

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: 301700 No. 10, Yuanhe Road, Wuqing Development Zone, Wuqing District, Tianjin

Patentee after: Tianjin Demak Medical Instrument Co.,Ltd.

Address before: 301700 No. 10, Yuanhe Road, Wuqing Development Zone, Wuqing District, Tianjin

Patentee before: Tianjin dimak Pharmaceutical Technology Co.,Ltd.

CP01 Change in the name or title of a patent holder